Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called second-harmonic generation, can monitor structural changes at any site within a protein, in real time. Since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how our bodies function and respond to treatments.


Biodesy Appoints Dominique Bridon as Chief Executive Officer

June 29, 2017

Biodesy article cited as one of the most popular in 2015

September 8, 2016


K4DD Meeting

October 16-18, 2017 Berlin, Germany

Next-Generation Antibodies and Protein Analysis‚Äč Meeting

October 16-17, 2017 ICC 'International Convention Center' Ghent, Belgium